Cargando…

Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing

Gene silencing mediated by small interfering RNA (siRNA) is a novel approach in the development of new cancer therapeutics. Polycations used for nucleic acid delivery still remain heterogeneous compounds, despite continuous progress in polymer synthetic technologies. Here we report the development o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dohmen, Christian, Fröhlich, Thomas, Lächelt, Ulrich, Röhl, Ingo, Vornlocher, Hans-Peter, Hadwiger, Philipp, Wagner, Ernst
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381594/ https://www.ncbi.nlm.nih.gov/pubmed/23344624 http://dx.doi.org/10.1038/mtna.2011.10

Ejemplares similares

Ligand Conjugated Multimeric siRNAs Enable Enhanced Uptake and Multiplexed Gene Silencing
por: Brown, Jonathan M., et al.
Publicado: (2019)

DNA as Tunable Adaptor for siRNA Polyplex Stabilization and Functionalization
por: Heissig, Philipp, et al.
Publicado: (2016)

In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice
por: Shi, Qin, et al.
Publicado: (2018)

Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect
por: Gaziova, Zuzana, et al.
Publicado: (2014)

Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene-silencing effects and siRNA biodistribution in mice
por: Hattori, Yoshiyuki, et al.
Publicado: (2020)

Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors
por: Urbiola, Koldo, et al.
Publicado: (2018)

Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells
por: Hattori, Yoshiyuki, et al.
Publicado: (2019)

Generation and validation of structurally defined antibody–siRNA conjugates
por: Nanna, Alex R, et al.
Publicado: (2020)

Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies
por: Fernandes, Julio C, et al.
Publicado: (2012)

Optimized siRNA-PEG Conjugates for Extended Blood Circulation and Reduced Urine Excretion in Mice
por: Iversen, Frank, et al.
Publicado: (2013)

Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene Silencing
por: Patil, Mahesh L., et al.
Publicado: (2011)

Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth
por: Khan, Tayeba, et al.
Publicado: (2016)

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
por: Ngamcherdtrakul, Worapol, et al.
Publicado: (2018)

Polymerized Selenium Nanoparticles for Folate-Receptor-Targeted Delivery of Anti-Luc-siRNA: Potential for Gene Silencing
por: Maiyo, Fiona, et al.
Publicado: (2020)

Interfering with disease: a progress report on siRNA-based therapeutics
por: de Fougerolles, Antonin, et al.
Publicado: (2007)

Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis
por: Meyer, Ingmar Sören, et al.
Publicado: (2018)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Therapeutic siRNA silencing in inflammatory monocytes
por: Leuschner, Florian, et al.
Publicado: (2011)

Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA
por: Liu, Xiaoxia, et al.
Publicado: (2014)

Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration
por: Ferrés-Coy, A, et al.
Publicado: (2016)

Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy
por: Ly, Socheata, et al.
Publicado: (2020)

Targeted delivery and enhanced gene-silencing activity of centrally modified folic acid–siRNA conjugates
por: Salim, Lidya, et al.
Publicado: (2020)

Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs
por: Shmushkovich, Taisia, et al.
Publicado: (2018)

Chaperonin–Dendrimer Conjugates for siRNA Delivery
por: Nussbaumer, Martin G., et al.
Publicado: (2016)

Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022)

Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
por: Foster, Donald J., et al.
Publicado: (2018)

Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer
por: Minassian, Georges, et al.
Publicado: (2023)

Biodegradable Nanoparticles of mPEG-PLGA-PLL Triblock Copolymers as Novel Non-Viral Vectors for Improving siRNA Delivery and Gene Silencing
por: Du, Jing, et al.
Publicado: (2012)

Molecular Umbrella Conjugate for the Ocular Delivery of siRNA
por: Janout, Vaclav, et al.
Publicado: (2014)

The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
por: Zhang, Lei, et al.
Publicado: (2022)

In vivo silencing of alpha-synuclein using naked siRNA
por: Lewis, Jada, et al.
Publicado: (2008)

High potency silencing by single-stranded boranophosphate siRNA
por: Hall, Allison H. S., et al.
Publicado: (2006)

Primary and Secondary siRNAs in Geminivirus-induced Gene Silencing
por: Aregger, Michael, et al.
Publicado: (2012)

Chitosan Hydrogel as siRNA vector for prolonged gene silencing
por: Ma, Zhiwei, et al.
Publicado: (2014)

siRNA Versus miRNA as Therapeutics for Gene Silencing
por: Lam, Jenny K W, et al.
Publicado: (2015)

Strategies for Improving siRNA-Induced Gene Silencing Efficiency
por: Safari, Fatemeh, et al.
Publicado: (2017)

Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017)

TLR agonist–Stat3 siRNA conjugates: cell-specific gene silencing and enhanced antitumor immune responses
por: Kortylewski, Marcin, et al.
Publicado: (2009)

Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence
por: Han, Xiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0hmcvi7gsmgf0o3a5217gkheg